Danaher: Q3 revenue up 8.5%, full-year adjusted EPS guidance raised
Danaher reported Q3 revenue up 8.5% and adjusted EPS up 11.5% to $2.11, lifting its 2026 adjusted EPS guidance to $8.57–$8.62 per share.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, Danaher's third-quarter revenue rose 8.5% to $6.554 billion. Adjusted earnings per share increased 11.5% to $2.11.
Core growth excluding respiratory testing was 5.5%. The company also raised its 2026 adjusted EPS guidance to a range of $8.57–$8.62.
why it matters
Two signals matter for the market: improving end-market trends and a higher profit outlook. Results like these support expectations for the life sciences and medtech sector, where demand and margins directly shape valuations of large players.
market impact
Life sciences and medtech sector: strong results and a higher outlook support Danaher shares
tags
instruments
sources
- DHR: Revenue rose 8.5%, adjusted EPS 11.5%, and FY EPS guidance increased — TradingView, 21 October 2026 at 10:02 UTC
- DHR: Q3 revenue grew 8.5%; adjusted EPS rose 11.5% to $2.11 — TradingView, 21 October 2026 at 10:06 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗